Back

ISO 17593:2022

Clinical laboratory testing and in vitro medical devices — Requirements for in vitro monitoring systems for self-testing of oral anticoagulant therapy

General information
Valid from 11.03.2022
Directives or regulations
None
Standard history
Status
Date
Type
Name
11.03.2022
Main
17.04.2007
Main
This document specifies requirements for in vitro measuring systems for self-monitoring of vitamin-K antagonist oral anticoagulation therapy, including performance, quality assurance and user training and procedures for the validation of performance by the intended users under actual and simulated conditions of use. This document applies solely to prothrombin time measuring systems used by lay persons for monitoring their own vitamin-K antagonist oral anticoagulation therapy, and which report results as international normalized ratios (INR). This document is applicable to manufacturers of such systems and those other organizations (e.g. regulatory authorities and conformity assessment bodies) having the responsibility for assessing the performance of these systems. This document is not applicable to: —    in vitro measuring systems for coagulation quantities assessing vitamin-K antagonist oral anticoagulation therapy used by physicians or healthcare providers; —    non-vitamin-K antagonist oral anticoagulation therapy (e.g. dabigatran); —    a comprehensive evaluation of all possible factors that can affect the performance of these systems; —    the medical aspects of oral-anticoagulation therapy.
*
*
*
PDF
205.94 € incl tax
Paper
205.94 € incl tax
Standard monitoring
Customers who bought this item also bought
Main

EVS-EN ISO 22442-3:2008

Medical devices utilizing animal tissues and their derivatives - Part 3: Validation of the elimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents
Newest version Valid from 07.02.2008
Main

ISO/TR 22442-4:2010

Medical devices utilizing animal tissues and their derivatives -- Part 4: Principles for elimination and/or inactivation of transmissible spongiform encephalopathy (TSE) agents and validation assays for those processes
Newest version Valid from 16.11.2010
Main

EVS-EN ISO 22442-1:2020

Medical devices utilizing animal tissues and their derivatives - Part 1: Application of risk management (ISO 22442-1:2020)
Newest version Valid from 31.12.2020
Main

EVS-EN ISO 22442-2:2020

Medical devices utilizing animal tissues and their derivatives - Part 2: Controls on sourcing, collection and handling (ISO 22442-2:2020)
Newest version Valid from 31.12.2020